100 Percent Fed Up By Danielle
Regeneron Pharmaceuticals said on Monday it would buy 23andMe out of bankruptcy for $256 million.
The acquisition gives Regeneron the company’s genetic samples and data for millions of individuals.
Regeneron Pharmaceuticals to buy 23andMe for $256M — taking control of genetic data of millions https://t.co/wh3uEsfQH7 pic.twitter.com/1bg9I6tUzi
— New York Post (@nypost) May 19, 2025
From the New York Post:
It will acquire 23andMe’s Personal Genome Service, Total Health and Research Services and its large biobank, including genetic data of more than 15 million customers – raising privacy concerns from individuals who had willingly handed over the samples to completely different owners.
All of 23andMe’s genetic testing services will continue uninterrupted, and the deal is expected to close in the third quarter of 2025 pending bankruptcy court and regulatory approvals, Regeneron said…
READ FULL ARTICLE HERE… (100percentfedup.com)
Home | Caravan to Midnight (zutalk.com)
